Transcatheter Technologies Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 2

Employees

  • Latest Deal Type
  • M&A

Transcatheter Technologies General Information

Description

Developer of the aortic valve for aortic therapy. The company develops medical devices and implantation systems which help to reduce the trauma of open-heart valve surgeries.

Contact Information

Website
www.transcathetertechnologies.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Am BioPark 13
  • 93053 Regensburg
  • Germany
Primary Industry
Therapeutic Devices
Acquirer
Venus Medtech
Corporate Office
  • Am BioPark 13
  • 93053 Regensburg
  • Germany

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Transcatheter Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 15-Apr-2016 Completed Generating Revenue
4. Early Stage VC (Series B) 02-Jun-2014 Completed Startup
3. Early Stage VC (Series A) 01-Jan-2011 Completed Startup
2. Grant 29-Jun-2010 $6.11K $818K Completed Startup
1. Seed Round 01-Jan-2009 $818K $818K Completed Startup
To view Transcatheter Technologies’s complete valuation and funding history, request access »

Transcatheter Technologies Patents

  • 28

    Total Documents Applications and Grants

  • Total Patents Families

  • 23

    Granted

  • 4

    Pending

  • Expiring in next 12 mo

Transcatheter Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10736744-B2 Handle assembly for implant delivery apparatus comprising a force limiter, a displacement limiter and/or a brake frame assembly Active 31-Jul-2013
US-20160158010-A1 Handle assembly for implant delivery apparatus comprising a force limiter, a displacement limiter and/or a brake frame assembly Active 31-Jul-2013
US-10064721-B2 Handle assembly for implant delivery apparatus comprising a force limiter, a displacement limiter and/or a brake frame assembly Active 31-Jul-2013
US-10736743-B2 Handle assembly for implant delivery apparatus comprising a force limiter, a displacement limiter and/or a brake frame assembly Active 31-Jul-2013
US-20160250051-A1 Set comprising a catheter and a valve supporting implant Inactive 31-Jul-2013 A61F2/95
To view Transcatheter Technologies’s complete patent history, request access »

Transcatheter Technologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Transcatheter Technologies Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bayern Kapital Venture Capital Minority
Clusterfonds EFRE Bayern Venture Capital Minority
FVW Investments Venture Capital Minority
High-Tech Gründerfonds Venture Capital Minority
KfW Group Investment Bank Minority
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial

Transcatheter Technologies FAQs

  • When was Transcatheter Technologies founded?

    Transcatheter Technologies was founded in 2009.

  • Where is Transcatheter Technologies headquartered?

    Transcatheter Technologies is headquartered in Regensburg, Germany.

  • What is the size of Transcatheter Technologies?

    Transcatheter Technologies has 2 total employees.

  • What industry is Transcatheter Technologies in?

    Transcatheter Technologies’s primary industry is Therapeutic Devices.

  • Is Transcatheter Technologies a private or public company?

    Transcatheter Technologies is a Private company.

  • What is Transcatheter Technologies’s current revenue?

    The current revenue for Transcatheter Technologies is .

  • How much funding has Transcatheter Technologies raised over time?

    Transcatheter Technologies has raised $3.07M.

  • Who are Transcatheter Technologies’s investors?

    Bayern Kapital, Clusterfonds EFRE Bayern, FVW Investments, High-Tech Gründerfonds, and KfW Group are 5 of 11 investors who have invested in Transcatheter Technologies.

  • When was Transcatheter Technologies acquired?

    Transcatheter Technologies was acquired on 15-Apr-2016.

  • Who acquired Transcatheter Technologies?

    Transcatheter Technologies was acquired by Venus Medtech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »